EXC · Categories · Downgrades
EXC - Analyst downgrades
Exelon Corporation (EXC) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for EXC
- Exelon downgraded by Jefferies with a new price targetJefferies downgraded Exelon from Buy to Hold and set a new price target of $50.00
- Exelon downgraded by BMO Capital Markets with a new price targetBMO Capital Markets downgraded Exelon from Outperform to Market Perform and set a new price target of $49.00
- Exelon downgraded by Barclays with a new price targetBarclays downgraded Exelon from Overweight to Equal Weight and set a new price target of $49.00
- Exelon downgraded by Mizuho with a new price targetMizuho downgraded Exelon from Outperform to Neutral and set a new price target of $48.00
- Exelon downgraded by Wolfe ResearchWolfe Research downgraded Exelon from Outperform to Peer Perform
- Exelon downgraded by KeyBanc Capital Markets with a new price targetKeyBanc Capital Markets downgraded Exelon from Sector Weight to Underweight and set a new price target of $39.00
- Exelon downgraded by Evercore ISI with a new price targetEvercore ISI downgraded Exelon from Outperform to In-line and set a new price target of $48.00
- Exelon downgraded by Seaport Research PartnersSeaport Research Partners downgraded Exelon from Buy to Neutral
- Exelon downgraded by UBS with a new price targetUBS downgraded Exelon from Buy to Neutral and set a new price target of $37.00 from $47.00 previously
- Exelon downgraded by JP Morgan with a new price targetJP Morgan downgraded Exelon from Overweight to Neutral and set a new price target of $41.00
- Exelon downgraded by Morgan Stanley with a new price targetMorgan Stanley downgraded Exelon from Overweight to Equal-Weight and set a new price target of $38.00 from $45.00 previously
- Exelon downgraded by Evercore ISIEvercore ISI downgraded Exelon from Outperform to In-line
- Exelon downgraded by Guggenheim with a new price targetGuggenheim downgraded Exelon from Buy to Neutral and set a new price target of $40.00 from $44.00 previously
- Exelon downgraded by Mizuho with a new price targetMizuho downgraded Exelon from Buy to Neutral and set a new price target of $40.00 from $45.00 previously
- Exelon downgraded by KeyBanc Capital MarketsKeyBanc Capital Markets downgraded Exelon from Overweight to Sector Weight
- Exelon downgraded by Scotiabank with a new price targetScotiabank downgraded Exelon from Sector Outperform to Sector Perform and set a new price target of $44.00 from $55.00 previously
- Exelon downgraded by Goldman Sachs with a new price targetGoldman Sachs downgraded Exelon from Buy to Neutral and set a new price target of $44.00 from $62.00 previously
- Exelon downgraded by Wells Fargo with a new price targetWells Fargo downgraded Exelon from Overweight to Equal-Weight and set a new price target of $45.00
- Exelon downgraded by RBC Capital with a new price targetRBC Capital downgraded Exelon from Outperform to Sector Perform and set a new price target of $46.00 from $66.00 previously
- Exelon downgraded by Vertical Research with a new price targetVertical Research downgraded Exelon from Buy to Hold and set a new price target of $45.00
- Exelon downgraded by Mizuho with a new price targetMizuho downgraded Exelon from Buy to Neutral and set a new price target of $57.00 from $55.00 previously